Urgent: Top health researcher blows whistle on Big Pharma...

The 6 Minutes That Could Put Big Pharma out of Business September 13, 2015 Urgent: Top health researcher blows whistle on Big Pharma... Dear Rude Awakening Reader, This is a fast-developing story, but here's what we know so far... An insider has just blown the whistle on one of the biggest scandals of the last 100 years... And experts are floored! In just 6 minutes and 12 seconds, one top researcher reveals a simple 90-day Alzheimer's treatment that could put Big Pharma out of business. This new protocol could cost Big Pharma billions and make many patented drugs irrelevant. Every American over 55 needs to hear this story. Click here for full details... Open the doc to see the protocol. Regards, Greg Guenthner Managing editor, The Rude Awakening The Rude Awakening is committed to protecting and respecting your privacy. We do not rent or share your email address. By submitting your email address, you consent to Agora Financial delivering daily email issues and advertisements. To end your Rude Awakening e-mail subscription and associated external offers sent from The Rude Awakening, click here. Please read our Privacy Statement. For any further comments or concerns please email us at rude@agorafinancial.com. If you are you having trouble receiving your Rude Awakening subscription, you can ensure its arrival in your mailbox by whitelisting The Rude Awakening. © 2015 Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security they personally recommend to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.